Transcription of for BIKTARVY. BIKTARVY ...
{{id}} {{{paragraph}}}
Example: barber
for BIKTARVY. BIKTARVY ...
gilead sciences 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY . BIKTARVY (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial Approval: 2018 WARNING: POST TREATMENT ACUTE EXACERBATION OF HEPATITIS B See full prescribing information for complete boxed warning. Severe acute exacerbations of hepatitis B have been reported in patients who are coinfected with HIV-1 and HBV and have discontinued products containing emtricitabine (FTC) and/or tenofovir disoproxil fumarate (TDF), and may occur with discontinuation of BIKTARVY . Closely monitor hepatic function in these patients. If appropriate, anti-hepatitis B therapy may be warranted. ( ) -------------------------- --INDICATIONS AND USAGE---------------------------- BIKTARVY is a three-drug combination of bictegravir (BIC), a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection in
Gilead Sciences 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BIKTARVY safely and effectively.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: